Upregulated at both 2 h and 3 day post-METH |
EIF2 signaling |
TCR |
RNA post-transcriptional modification |
Regulation of eIF4 and p70S6K signaling |
DOT1L |
Protein synthesis |
mTOR signaling |
HSP90B1 |
Gene expression |
Hepatic fibrosis/hepatic stellate cell activation |
miR-542-3p (miRNAs w/seed GUGACAG) |
Cell morphology |
Complement system |
ELAVL1 |
Cell-to-cell signaling and interaction |
Downregulated at both 2 h and 3 day post-METH |
Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde |
BHLHA15 |
Cellular assembly and organization |
NAD biosynthesis II (from tryptophan) |
SOX11 |
DNA replication, recombination, and repair |
Leukotriene biosynthesis |
ERBB2 |
Cell cycle |
-Glutamyl cycle |
NAMPT |
Cellular growth and proliferation |
Mismatch repair in eukaryotes |
CERS6 |
Cell morphology |
Upregulated at 2 h and downregulated at 3 day |
-Linolenate biosynthesis II (animals) |
FAM103A1 |
Cellular assembly and organization |
Myc mediated apoptosis signaling |
IKBKE |
DNA replication, Recombination and repair |
Glycine biosynthesis I |
PIM1 |
Cell morphology |
Pancreatic adenocarcinoma signaling |
RELB |
Cell death and survival |
S-adenosyl-L-methionine biosynthesis |
NFKB2 |
Cell cycle |
Downregulated at 2 h and upregulated at 3 day |
NAD salvage pathway II |
NDRG1 |
Lipid metabolism |
IL-22 signaling |
COL18A1 |
Small molecule biochemistry |
Natural killer cell signaling |
CDK4 |
Cell morphology |
PI3K/AKT signaling |
PDLIM2 |
Cellular function and maintenance |
Interferon signaling |
CLDN7 |
Cell death and survival |